Isabella Lurje

13PUBLICATIONS
64CO-AUTHORS
Innate immunityDeep learningPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Sep 29, 2026
Hypothermic oxygenated and normothermic machine perfusion mitigate innate systemic and hepatic inflammation after liver transplantation.

|Jun 17, 2026
Counterfactual Diffusion Models Provide Interpretable Explanations of Artificial Intelligence Models in Pathology.

|Jun 03, 2026
TERT rs10069690 variant is linked to reduced cholangiocarcinoma incidence but adverse prognosis in patients undergoing resection.

|Feb 18, 2025
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) Impacts Long-Term Outcomes After Curative-Intent Surgery for Hepatocellular Carcinoma.

Deniz Uluk, Justus Pein, Sophia Herda

|Nov 09, 2024
High Expression of the Tumor Suppressor Protein ITIH5 in Cholangiocarcinomas Correlates with a Favorable Prognosis.

Verena J Dreyer, Jia-Xin Shi, Michael Rose

|Feb 05, 2024
Improved outcomes after hypothermic oxygenated machine perfusion in liver transplantation-Long-term follow-up of a multicenter randomized controlled trial.

Zoltan Czigany, Deniz Uluk, Sandra Pavicevic

Pageof 3

Frequent Collaborators

10 joint publications

Frank Tacke

8 joint publications

Georg Lurje

3 joint publications

Zoltan Czigany

3 joint publications

Deniz Uluk